Webinars

A journey into the future of health

An innovative series of live virtual events to explore the future frontiers of Medicine, featuring some of Hadassah's top visionaries from Jerusalem’s two world-renowned hospitals. Presented by Hadassah International. Read more

Emergency Medicine COVID-19: The Israel Experience

Hadassah Australia is proud to present this interactive exchange providing a unique insight into the management of COVID 19 in Israel. Read more

COVID-19: Can We Win The War?

HAMRC is honoured to present Dr Norman Swan and a panel of distinguished experts in medical research and vaccine developments to discuss challenging questions surrounding COVID-19 and what it means for Australia’s research future. Read more

Latest

Hadassah Develops its own CAR T Therapy to Treat Multiple Myeloma

“Many of the hospital staff treating me used to be my patients. Now my life is in their hands,” relates Hadassah Medical Organization social worker Tali Rosen. Since Rosen’s job as a Hadassah social worker was a challenging one, she waved away the initial tiredness and aching bones she experienced. When repeated infections became more than a nuisance, she had herself tested. Rosen was diagnosed with multiple myeloma, cancer within the spongy bone marrow.
HADASSAH INTERNATIONAL ANNUAL REPORT 2020 – TOGETHER WE LIVE

We are pleased to share with you Hadassah International’s second Annual Report/Year In Review, available in digital format, entitled “Hadassah International – Together We Live”.
From Hidden Child During the Holocaust to Hadassah Surgeon

Dr Shaul Perlberg, age 80, is still practising urology at Hadassah Hospital Mount Scopus, as he has for many years. But it wasn’t until 16 years ago that he decided to reveal the incredible story of his childhood, the reunion with his mother after the Holocaust, their move to Israel, and the way he met the love of his life, Raya.
Hadassah Study Finds Covid-19 Vaccine Doesn’t Affect Fertility

A Hadassah Medical Organization study reveals that neither the COVID-19 vaccine nor COVID-19 itself has any detrimental effects on female fertility.

Dr Phillip Brenner
Partnering with Israel

With every dollar invested in medical research, Australia gains a $3.90 return to the economy. Many countries competing with Australia have increased their investment. Israel currently has the highest spend globally at 4.25 per cent – thus is a powerful partner for research and development. There are other synergies between our countries including a well-known history of collaboration leading to successful outcomes, medically and commercially.
At risk: Exploring the link between prematurity and chronic kidney disease

Catch up on this important webinar bringing you expert and personal insights on the link between prematurity and chronic kidney disease.
Pledge Gifts

Pledge gifts provide researchers with a sense of security for their projects so they can focus on their work. It can help us plan and budget in advance for the calibre of research projects we can support.
Hadassah Study Finds Covid-19 Vaccine Doesn’t Affect Fertility

A Hadassah Medical Organization study reveals that neither the COVID-19 vaccine nor COVID-19 itself has any detrimental effects on female fertility.
Research partnerships

In Hadassah Australia's journey to expand research partnerships, we have collaborated with leading Australian health organisations.
Gifts in Wills

Directing a Gift in your Will to medical research is a powerful way to protect future generations and continue your legacy beyond your lifetime. It is a meaningful and lasting statement of your life, passion and values.
About us

The HAMRC Foundation is a bold new initiative – a multi-centred collaborative research model that brings together the brightest minds from Israel’s Hadassah Hospital and leading research institutions in Australia and internationally to solve some of the most intractable health problems facing the world today.
Alan Liddle
Enlivex reports top-line results for Allocetra™ in treating Covid-19

Enlivex has reported positive top-line results from phase ii clinical trial evaluating Allocetra in severe and critical Covid-19 patients and provides a program update